New cancer pill tested, but study stopped early
Disease control
Terminated
This early-stage study tested an experimental oral drug called ATX-559 in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and understand side effects. The study was terminated early, so results are lim…
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:40 UTC